A Phase II Clinical Trial of Chiglitazar for NASH

NCT05193916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH

Interventions

DRUG: chiglitazar sodium tablets
DRUG: Placebo

Sponsor

Chipscreen Biosciences, Ltd.